High medication costs remain a significant barrier, with the average price of GLP-1 drugs reaching USD 1,200 per month, making them inaccessible to many
Insurance support: Ro can check benefits and submit prior authorization when the plan may cover medication
The Cleveland Clinic explains that GLP-1 agonist medications like Ozempic and Mounjaro work by triggering your pancreas to release more insulin, adding: The slowed digestion also helps decrease blood sugar spikes. These factors can play into appetite, digestion, the metabolization of food into energyand in turn, possibly weight loss
the CagriSema combination NDA is under review and retatrutide is at the Phase 3 stage
Oral GLP-1 Approaches Commercial Inflection by 2028 GLP-1 Weight Loss Drug Market Revenue Share, CAGR, and Primary Drivers by Route 2026 Subcutaneous injectable administration commands 81.7% GLP-1 market revenue share in 2026 as the weekly autoinjector format delivers clinical efficacy, dose consistency, and patient convenience superior to daily injectable alternatives
But a tool sold as a cure to a population financially stretched to afford it is not healthcare innovation